Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Profit After Tax (2016 - 2025)

Xtant Medical Holdings has reported Profit After Tax over the past 16 years, most recently at $57000.0 for Q4 2025.

  • Quarterly Profit After Tax rose 101.8% to $57000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 130.23% year-over-year, with the annual reading at $5.0 million for FY2025, 130.23% up from the prior year.
  • Profit After Tax was $57000.0 for Q4 2025 at Xtant Medical Holdings, down from $1.3 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $9.2 million in Q3 2023 and troughed at -$5.0 million in Q3 2024.
  • The 5-year median for Profit After Tax is -$2.1 million (2023), against an average of -$1.2 million.
  • Year-over-year, Profit After Tax crashed 7531.03% in 2022 and then soared 492.31% in 2023.
  • A 5-year view of Profit After Tax shows it stood at -$2.3 million in 2021, then rose by 3.24% to -$2.2 million in 2022, then tumbled by 94.79% to -$4.3 million in 2023, then grew by 26.45% to -$3.2 million in 2024, then skyrocketed by 101.8% to $57000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Profit After Tax are $57000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.6 million (Q2 2025).